Literature DB >> 2632388

Reversal of changes of lipid peroxide, xanthine oxidase and superoxide dismutase by cardio-protective drugs in isoproterenol induced myocardial necrosis in rats.

S Kaul, N K Kapoor.   

Abstract

In myocardial necrosis produced by isoproterenol (beta-adrenergic agonist) marked increase in creatine phosphokinase, phospholipase and significant decrease in cardiac glycogen and phospholipid levels were observed. The enhanced levels of lipid peroxides, xanthine oxidase activity and lowering of superoxide dismutase may lead to excessive formation of free radicals resulting in cardiac cell damage. Nifedipine--a calcium antagonist, Propranolol--a beta-blocker and guggulsterone a lipid lowering agent showed marked reversal of these metabolic changes related to ischemia induced by isoproterenol.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2632388

Source DB:  PubMed          Journal:  Indian J Exp Biol        ISSN: 0019-5189            Impact factor:   0.818


  4 in total

1.  Cardioprotective activity of synthetic guggulsterone (E and Z-isomers) in isoproterenol induced myocardial ischemia in rats: A comparative study.

Authors:  Ramesh Chander; Farhan Rizvi; A K Khanna; Ram Pratap
Journal:  Indian J Clin Biochem       Date:  2003-07

2.  Estimation of Guggulsterone E and Z in the Guggul-based Commercial Formulations Using High-performance Thin-layer Chromatography.

Authors:  Pramod Kumar Sairkar; Anjana Sharma; N P Shukla
Journal:  J Pharm Bioallied Sci       Date:  2017 Jan-Mar

Review 3.  Googling the Guggul (Commiphora and Boswellia) for Prevention of Chronic Diseases.

Authors:  Ajaikumar B Kunnumakkara; Kishore Banik; Devivasha Bordoloi; Choudhary Harsha; Bethsebie L Sailo; Ganesan Padmavathi; Nand K Roy; Subash C Gupta; Bharat B Aggarwal
Journal:  Front Pharmacol       Date:  2018-08-06       Impact factor: 5.810

4.  Protective effect of guggulsterone against cardiomyocyte injury induced by doxorubicin in vitro.

Authors:  Wen-Ching Wang; Yih-Huei Uen; Ming-Long Chang; Khoot-Peng Cheah; Joe-Sharg Li; Wen-Yu Yu; Kock-Chee Lee; Cheuk-Sing Choy; Chien-Ming Hu
Journal:  BMC Complement Altern Med       Date:  2012-08-27       Impact factor: 3.659

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.